Adagene ADAG
NASDAQ ADAG
$3.63 -0.06 (-1.63%)
As of: Sep 4, 2026 · 11:22 AM EDT

Adagene (ADAG) Shares Outstanding (2019 - 2026)

Adagene (ADAG) posted quarterly Shares Outstanding (Entity) of $59.0 million for Q4 2025, up 4.83% year-over-year from $56.3 million in Q4 2024, and little changed quarter-over-quarter from $58.9 million in Q2 2025.

Analysis

Adagene (ADAG) Shares Outstanding (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Shares Outstanding (Entity) for 7 consecutive years, with $59.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Shares Outstanding (Entity) rose 4.83% year-over-year to $59.0 million; the TTM figure through Dec 2025 stood at $59.0 million (up 4.83% YoY), while the FY2025 annual figure was $59.0 million, up 4.83% from the prior year.
  • Shares Outstanding (Entity) steadied at $59.0 million in Q4 2025 per ADAG's latest filing, from $58.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $59.0 million in Q4 2025 and bottomed at $36.4 million in Q2 2021.
  • Historically, Shares Outstanding (Entity) has averaged $51.3 million across 5 years, with a median of $54.7 million in 2023.
  • Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 213.67% — and 2023, when it gained 1.11%.
  • Adagene's Shares Outstanding (Entity) stood at $40.0 million in 2021, then jumped by 35.25% to $54.1 million in 2022, then rose by 1.11% to $54.7 million in 2023, then advanced by 2.83% to $56.3 million in 2024, then advanced by 4.83% to $59.0 million in 2025.
  • Business Quant data shows ADAG's Shares Outstanding (Entity) at $59.0 million in Q4 2025, $58.9 million in Q2 2025, and $56.3 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 210.89 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 445.06 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 217.35 Mn
10 Adagene 214.19 Mn 214.19 Mn - 59.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.01 Mn
Dec 31, 2025 59.01 Mn
Jun 30, 2025 56.29 Mn
Dec 31, 2024 56.29 Mn
Jun 30, 2024 54.74 Mn
Dec 31, 2023 54.74 Mn
Jun 30, 2023 54.14 Mn
Dec 31, 2022 54.14 Mn
Jun 30, 2022 50.03 Mn
Dec 31, 2021 50.03 Mn
Jun 30, 2021 15.95 Mn
Dec 31, 2020 15.95 Mn
Dec 31, 2019 15.18 Mn